Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."


Click Here For The Most Popular On Sunny Skyz

feel good videoDrive-Thru Safari Surprise: Woman Gets Up Close And Personal With Scottish Highland Cow

feel good storiesThis High School Tradition Is Bringing Millions To Tears - The Teachers' Reactions Are Everything

feel good storiesThis Magician's Mind-Bending Halloween Costume Has The Internet Stumped

feel good storiesDad Builds Incredible 65-Foot Pirate Ship Playset For His Kids

feel good storiesOver 130,000 Men Described The Woman They Love. Here Are The 15 Most Heartfelt Responses

feel good storiesER Physician Assistant Gets A Heartwarming Gift That Turns His Night Around

feel good videoDrummer's Unexpected Cartoon Sound Effect Has Lead Singer 'Fighting For His Life' On Stage

feel good videoShe Dressed As Her Coworker And He Could Not Stop Laughing

feel good videoMom's Hilarious Parody Of Fitness Advice Is All Too Relatable

feel good videoThis Toddler's Grandpa Is A Triplet. Her Name For All Of Them Is Going Viral

feel good videoDoorbell Camera Captures Heart-Stopping Moment Illinois Neighbor Saves Choking Child